You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-23. New clients entering outpatient treatment: distribution of secondary drug used at treatment in 2004: average for those EU countries supplying data

Secondary drug	Number of citations by new clients	% total number of new clients
Volatile	263	0.3
Other substances	634	0.6
Hallucinogens	1951	2.0
Hypnotics and sedatives	4547	4.6
Stimulants	9119	9.1
Opioids	9413	9.4
Cocaine	11588	11.6
Cannabis	24575	24.6
Alcohol	29983	30.0
Total number of new clients		99852
Notes The countries supplying data are: CZ, DK, DE, EL, IT, CY, HU, MT, NL, SI, SK, SE, UK, BG. The number of treatment clients in each country is listed in Table TDI-7. See also 'General notes for interpreting data' on the Explanatory notes and help page. Source: 2005 Reitox national reports - TDI outpatient treatment centres

Data filter | tditab23-en.xml